Fluzone High Dose Vaccine

BIOLOGICAL3 trials

Sponsors

St. Jude Children's Research Hospital, Yale University, Longeveron Inc.

Conditions

Aging FrailtyCancerHIVInfluenzaMGUSMultiple MyelomaPlasma Cell DisordersWaldenstrom's Macroglobulinemia

Phase 1

Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty

CompletedNCT02982915

Longeveron Inc.Aging Frailty

Start: 2016-11-30End: 2022-09-30Updated: 2022-11-04

Phase 2

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

CompletedNCT01205581

St. Jude Children's Research HospitalCancer, HIV

Start: 2010-09-30End: 2013-08-31Updated: 2016-09-23

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients

CompletedNCT02566265

Yale UniversityInfluenza, MGUS, Multiple Myeloma +2

Start: 2015-09-30End: 2018-06-30Updated: 2019-01-30

Related Papers

Clinical Study of Mesenchymal Stem/Stromal Cell Therapy for the Treatment of Frailty: A Proposed Experimental Design for Therapeutic and Mechanistic Investigation

The Journals of Gerontology Series A2021-10-283 citations

Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias

Blood Advances2021-03-0821 citations